Week in Review

This week, the top managed care stories included a new direction for the Center for Medicare and Medicaid Innovation; a bipartisan group of governors spoke out against the latest effort to repeal the Affordable Care Act; and the World Health Organization warned that antibiotics currently being developed were not enough to fight antibiotic-resistant infections.

This week, the top stories in managed care included competing healthcare reform bills in the Senate; the FDA announced progress in clearing up the backlog of orphan drug requests; and a study examines how much it really costs to bring a drug to the market.

This week, the top managed care stories included more insurers rolling back participation in Affordable Care Act exchanges, while governors testify ways to stabilize the market; the FDA put 3 combination trials of nivolumab on hold; and a study finds very few visits to the emergency department are truly avoidable.

This week, the top managed care stories included responses to the disaster in Houston after Hurricane Harvey; the approval of the first gene therapy in the United States; and a new cardiovascular indication for a popular drug to treat type 2 diabetes.

This week, the top stories in managed care include a study on which mammogram recommendations to follow; findings that continuous glucose monitoring benefits patients with type 2 diabetes; and a new position statement on treating patients with diabetes and hypertension.

This week, the top managed care articles included a report from the Congressional Budget Office on the impact of eliminating the cost-sharing reduction payments; a decision from CMS to eliminate 2 mandatory bundled payment programs; and a new value-based alliance that called for ending use of a test for diagnosing heart attacks.

This week, the top managed care stories included a look at the politics of right-to-try legislation; the success of FDA's expedited review programs; and a review on the best way to prevent cardiovascular risk in patients with diabetes.

This week, the top managed care stories included bipartisan proposals for fixing the Affordable Care Act (ACA); FDA approved a targeted therapy for patients with acute myeloid leukemia who have a rare genetic mutation; and a study found that more patients have gained access to clinical trials after the ACA was implemented.

This week, the top managed care stories included the Senate rejecting multiple measures to repeal and replace the Affordable Care Act; calls for new payment models in behavioral healthcare; and 2 studies on empowering consumers to find the best prices for medications.

This week, the top managed care news included insurers staying away from HealthCare.gov, where you live can affect your chance of surviving cancer, and a new deal could help people on Medicare with diabetes.

This week, the top managed care news included Senators hearing from their constituents about the healthcare bill; a dispute with a health insurer shut down a state government for 3 days; and the FDA approved a new test for leukemias and lymphomas.

This week, the top managed care news included the Senate announcing it would delay voting on the healthcare bill until after July 4; the FDA outlined a plan to expedite drug approvals; and Joe and Jill Biden launched the Biden Cancer Initiative.

The top managed care stories this week included proposed rule changes to the implementation of the Medicare Access and CHIP Reauthorization Act; a study found Medicaid expansion increased emergency department utilization; and a diabetes drug received a new cardiovascular indication.

This week, the top managed care news included a report from CMS that found 2 million people dropped Obamacare coverage after failing to pay their premiums; a study found the diabetes drug canagliflozin reduced cardiovascular risk; and the Supreme Court of the United States rules in favor of biosimilars.

This week, the top managed care stories included findings that some cancers are being diagnosed earlier after people gain coverage under the Affordable Care Act; a new poll gauged Americans' views on Medicaid; and JDRF launched a new campaign to meet the needs of people with type 1 diabetes.

This week, the top managed care stories include an announcement that CMS will take Social Security numbers off Medicare cards; a national plan to combat chronic obstructive pulmonary disease was released; and a nutrition advocacy group calls on FDA to stick with the schedule for a new nutrition facts label.

This week, the top managed care news included the Congressional Budget Office's new score for the American Health Care Act; the White House released its fiscal year 2018 budget; and a cancer drug approval that is a first for the FDA.

This week, the top managed care stories included the White House budget director hinting at mandatory drug rebates in Medicare; a global cyberattack locked physicians out of patient records; and the National Diabetes Prevention Program released promising data from the first 4 years.

This week, the top managed care stories included the Senate began working on its own Obamacare replacement bill; Scott Gottlieb, MD, was confirmed as FDA commissioner; and coverage from Digestive Disease Week.

This week in managed care, the top stories included a surprising shake-up in leadership at Molina Healthcare; feedback for the Oncology Care Model; and Healthy Vision Month is focusing on women.

This week, the top managed care stories included President Donald Trump's nominee passing a Senate committee; community oncologists meet to discuss the Cancer Moonshot; and a study finds obesity shortens more lives than cigarettes.

This week, the top managed care stories included a new rule from CMS to end abuse on the Affordable Care Act insurance exchanges; a study that indicates type 2 diabetes may possibly be reversed; and CareMore unveils a new care model that takes place in the dentist's chair.

This week, the top managed care stories include an update for prostate cancer screening guidelines; the consequences of conflicting breast cancer guidelines; and Florida seeks work requirements for Medicaid.

This week, the top stories in managed care included the president's pick to lead the FDA testified before a Senate committee; Mylan recalls EpiPen batches and faces a class action lawsuit; and a study ties being a night owl to increased depression in patients with diabetes.

This week, the top managed care news included new radiology guidelines for early-stage breast cancer; 4 continuing healthcare challenges for President Donald Trump; and Medicare coverage for Dexcom's continuous glucose monitor.

This week, the top stories in managed care included last-minute changes to Republicans' bill to repeal the Affordable Care Act; a lack of votes to pass the GOP health bill; and promising study results on PCSK9 inhibitors and SGLT2 inhibitors.

This week, the top managed care stories included the Congressional Budget Office releasing its rating of the GOP's health plan, the Senate voted to confirm Seema Verma for CMS administrator, and Scott Gottlieb, MD, was nominated to lead the FDA.

This week, the top managed care news included a bill from House Republicans to repeal and replace the Affordable Care Act, a new program at Walgreens to train pharmacists on an advanced cancer-care curriculum, and findings that health coaching helps the neediest patients most.